PTC Therapeutics, Inc. (PTCT)
60.49
-0.48
(-0.79%)
USD |
NASDAQ |
Nov 17, 16:00
60.49
0.00 (0.00%)
After-Hours: 20:00
PTC Therapeutics Price : 60.49 for Nov. 17, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 63.26 | 63.94 | 60.62 | 60.97 | 745574.0 |
| Nov 13, 2026 | 63.12 | 63.74 | 62.51 | 63.49 | 502869.0 |
| Nov 12, 2026 | 64.59 | 64.86 | 63.24 | 63.36 | 538718.0 |
| Nov 11, 2026 | 64.02 | 65.04 | 63.62 | 64.91 | 724938.0 |
| Nov 10, 2026 | 64.46 | 65.15 | 63.52 | 64.14 | 630009.0 |
| Nov 09, 2026 | 66.90 | 66.90 | 64.12 | 65.03 | 843279.0 |
| Nov 06, 2026 | 65.99 | 66.67 | 65.15 | 65.44 | 898968.0 |
| Nov 05, 2026 | 68.80 | 69.59 | 65.45 | 65.67 | 1.239M |
| Nov 04, 2026 | 69.68 | 70.11 | 66.87 | 68.97 | 1.344M |
| Nov 03, 2026 | 64.14 | 68.72 | 63.16 | 68.12 | 2.644M |
| Nov 02, 2026 | 61.05 | 62.16 | 59.16 | 60.88 | 1.339M |
| Oct 30, 2026 | 64.75 | 65.34 | 59.64 | 59.97 | 2.358M |
| Oct 29, 2026 | 63.51 | 65.00 | 63.51 | 64.46 | 1.524M |
| Oct 28, 2026 | 61.82 | 63.11 | 61.00 | 63.02 | 909250.0 |
| Oct 27, 2026 | 61.07 | 62.31 | 59.87 | 62.09 | 1.117M |
| Oct 26, 2026 | 60.84 | 61.85 | 60.46 | 61.07 | 708776.0 |
| Oct 23, 2026 | 62.30 | 63.49 | 59.96 | 60.59 | 674207.0 |
| Oct 22, 2026 | 62.62 | 63.49 | 62.24 | 63.04 | 675445.0 |
| Oct 21, 2026 | 63.14 | 63.74 | 62.41 | 62.62 | 944163.0 |
| Oct 20, 2026 | 62.27 | 63.24 | 61.58 | 62.92 | 965774.0 |
| Oct 19, 2026 | 60.13 | 61.74 | 59.35 | 61.53 | 943991.0 |
| Oct 16, 2026 | 61.08 | 61.73 | 58.98 | 59.24 | 788980.0 |
| Oct 15, 2026 | 61.08 | 62.31 | 59.88 | 60.99 | 1.052M |
| Oct 14, 2026 | 59.30 | 60.69 | 58.80 | 59.67 | 1.520M |
| Oct 13, 2026 | 62.64 | 62.75 | 59.82 | 59.92 | 1.051M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 18.30 |
| Alnylam Pharmaceuticals, Inc. | 156.54 |
| Anika Therapeutics, Inc. | 12.89 |
| Savara, Inc. | 4.475 |
| Arrowhead Pharmaceuticals, Inc. | 42.96 |
Price Related Metrics
| PS Ratio | 4.433 |
| Earnings Yield | -2.33% |
| Market Cap | 5.053B |
| Operating PE Ratio | 20.54 |